Home Other Building Blocks Nbi-74330

Nbi-74330

CAS No.:
855527-92-3
Catalog Number:
AG00G3PA
Molecular Formula:
C32H27F4N5O3
Molecular Weight:
605.5821
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
99%
1 week
United States
$265
- +
10mg
99%
1 week
United States
$404
- +
25mg
99%
1 week
United States
$682
- +
50mg
99%
1 week
United States
$1237
- +
100mg
99%
1 week
United States
$1932
- +
Product Description
Catalog Number:
AG00G3PA
Chemical Name:
Nbi-74330
CAS Number:
855527-92-3
Molecular Formula:
C32H27F4N5O3
Molecular Weight:
605.5821
MDL Number:
MFCD11850718
IUPAC Name:
N-[(1R)-1-[3-(4-ethoxyphenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-2-[4-fluoro-3-(trifluoromethyl)phenyl]-N-(pyridin-3-ylmethyl)acetamide
InChI:
InChI=1S/C32H27F4N5O3/c1-3-44-24-11-9-23(10-12-24)41-30(39-29-25(31(41)43)7-5-15-38-29)20(2)40(19-22-6-4-14-37-18-22)28(42)17-21-8-13-27(33)26(16-21)32(34,35)36/h4-16,18,20H,3,17,19H2,1-2H3/t20-/m1/s1
InChI Key:
XMRGQUDUVGRCBS-HXUWFJFHSA-N
SMILES:
CCOc1ccc(cc1)n1c(nc2c(c1=O)cccn2)[C@H](N(C(=O)Cc1ccc(c(c1)C(F)(F)F)F)Cc1cccnc1)C
Properties
Complexity:
1020  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
605.205g/mol
Formal Charge:
0
Heavy Atom Count:
44  
Hydrogen Bond Acceptor Count:
10  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
605.594g/mol
Monoisotopic Mass:
605.205g/mol
Rotatable Bond Count:
9  
Topological Polar Surface Area:
88A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
5  
Literature
Title Journal
Label-free impedance responses of endogenous and synthetic chemokine receptor CXCR3 agonists correlate with Gi-protein pathway activation. Biochemical and biophysical research communications 20120309
Optimization of a series of quinazolinone-derived antagonists of CXCR3. Bioorganic & medicinal chemistry letters 20090901
Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist. The Journal of pharmacology and experimental therapeutics 20050601
Properties